J Cancer 2020; 11(22):6703. doi:10.7150/jca.53041

Erratum

B7-H3 promotes the cell cycle-mediated chemoresistance of colorectal cancer cells by regulating CDC25A: Erratum

Yanchao Ma1, Ruoqin Wang1, Huimin Lu1, Xiaomi Li1, Guangbo Zhang1,2,3, Fengqing Fu1,2,3, Lei Cao1,2,3, Shenghua Zhan1,2, Zhenxin Wang1,2,3, Zhongbin Deng4, Tongguo Shi1,2,3✉, Xueguang Zhang1,2,3✉, Weichang Chen1,2,3✉

1. Department of Gastroenterology & Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, 188 Shizi Road, Suzhou, China.
2. Jiangsu Key Laboratory of Clinical Immunology, Soochow University, 708 Renmin Road, Suzhou, China.
3. Jiangsu Key Laboratory of Gastrointestinal tumor Immunology, The First Affiliated Hospital of Soochow University, 708 Renmin Road, Suzhou, China.
4. James Graham Brown Cancer Center, Department of Microbiology &Immunology, University of Louisville, Kentucky 40202, USA.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Ma Y, Wang R, Lu H, Li X, Zhang G, Fu F, Cao L, Zhan S, Wang Z, Deng Z, Shi T, Zhang X, Chen W. B7-H3 promotes the cell cycle-mediated chemoresistance of colorectal cancer cells by regulating CDC25A: Erratum. J Cancer 2020; 11(22):6703. doi:10.7150/jca.53041. Available from http://www.jcancer.org/v11p6703.htm

File import instruction

Corrected-article in J Cancer, Volume 11, 2158